Results 191 to 200 of about 141,530 (342)

The Renin-Angiotensin-Aldosterone system in patients with depression compared to controls – a sleep endocrine study [PDF]

, 2003
Harald Murck, K. Held, Marc Ziegenbein, Heike Künzel, Kathrin Koch, Axel Steiger   +5 more
openalex   +1 more source

The Prevalence and Implications of Polypharmacy in Individuals With Type 1 Diabetes

Clinical Pharmacology &Therapeutics, Volume 119, Issue 3, Page 696-702, March 2026.
Polypharmacy is increasingly recognized as a relevant issue in diabetes care, but its prevalence and clinical relevance in individuals with type 1 diabetes remain underexplored. This study aimed to determine the prevalence of polypharmacy and to identify associated clinical and psychological factors. Participants were recruited from a tertiary diabetes
Namam Ali, Stephan van Erp, Cornelis Kramers, Cornelis J. Tack, Bastiaan E. de Galan   +4 more
wiley   +1 more source

Renin Angiotensin Aldosterone System Functions in Renovascular Hypertension

, 2021
José A. Gómez
openalex   +2 more sources

Benefits and harms of sodium‐glucose co‐transporter‐2 inhibitors (SGLT2‐I) and renin–angiotensin–aldosterone system inhibitors (RAAS‐I) versus SGLT2‐Is alone in patients with type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials [PDF]

, 2021
Samuel Seidu, Setor K. Kunutsor, Pınar Topsever, Kamlesh Khunti   +3 more
openalex   +1 more source

Characterizing Alzheimer’s Disease and Related Dementia in a Hypertension Population Within the State of Florida Using Electronic Health Record–Based Data

Clinical Pharmacology &Therapeutics, Volume 119, Issue 3, Page 751-762, March 2026.
Hypertension is a known modifiable risk factor for Alzheimer’s disease and related dementia (ADRD). However, it is unknown how variance in hypertension control, antihypertensive medications, and social determinants of health, such as social deprivation index (SDI), influence the risk of developing ADRD.
Eissa A. Jafari, Mona Alshahawey, Muhammad A. Zaman, Steven M. Smith, Yan Gong, Glenn E. Smith, Caitrin W. McDonough   +6 more
wiley   +1 more source

Beyond the circulating renin angiotensin aldosterone system

Frontiers in Endocrinology, 2014
Walmor eDe Mello
doaj   +1 more source

Crosstalk between renin and arachidonic acid (and its metabolites)

Lipids in Health and Disease
Renin plays a significant role in the regulation of blood pressure and fluid volume by modulating the renin‒angiotensin‒aldosterone (RAAS) system. Renin suppression reduces serum aldosterone levels and lowers blood pressure in addition to preserving ...
Undurti N. Das, Ahmet Hacimüftüoglu, Erol Akpinar, Mustafa Gul, A. M. Abd El-Aty   +4 more
doaj   +1 more source

#3375 The alternative pathway of the renin angiotensin aldosterone system is overactivated in severe COVID-19 at baseline [PDF]

Irene Martínez Díaz, Jordi Vilardell, Sara Núñez-Delgado, Pablo Garcı́a de Frutos, Jose T. Ortiz‐Pérez, Antonio Cano Cámara, Carmen Llorens Cebrià, Albert Morales, Conxita Jacobs Cachá, María José Soler Romeo   +9 more
openalex   +1 more source

Endothelin-1 receptor blockade induces upregulation of renin-angiotensin-aldosterone system expression in terms of blood pressure regulation [PDF]

, 2010
Bo Yang, Yundai Chen, Tian-de Li, Quan–Zhou Feng   +3 more
openalex   +1 more source

The renin–angiotensin–aldosterone system as a link between obesity and coronavirus disease 2019 severity [PDF]

, 2020
Ioannis Akoumianakis, Theodosios D. Filippatos   +1 more
openalex   +1 more source